Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

1,350

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Flublok Quadrivalent

Intramuscular injection of study vaccine

BIOLOGICAL

Inactivated Influenza Vaccine (IIV4)

Intramuscular injection of study vaccine

Trial Locations (10)

31406

Meridian Clinical Research, Savannah

33134

Clinical Research of South Florida, Coral Gables

57049

Meridian Research, Dakota Dunes

67207

Heartland Research Associates, LLC, Wichita

68005

Meridian Research, Bellevue

68164

Meridian Clinical Research, Omaha

70006

Benchmark Research, Metairie

76135

Benchmark Research - Fort Worth, Fort Worth

78705

Benchmark Reseach, Austin

95816

Benchmark Research - Sacramento, Sacramento

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

collaborator

Department of Health and Human Services

FED

lead

Protein Sciences Corporation

INDUSTRY